Eugen F. Mesaros
Publications by Year
Research Areas
Synthetic Organic Chemistry Methods, Lung Cancer Treatments and Mutations, Cancer therapeutics and mechanisms, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography
Most-Cited Works
- → Evolution of a Total Synthesis of (−)-Kendomycin Exploiting a Petasis−Ferrier Rearrangement/Ring-Closing Olefin Metathesis Strategy(2006)94 cited
- → Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)(2016)89 cited
- → Total Synthesis of (−)-Kendomycin Exploiting a Petasis−Ferrier Rearrangement/Ring-Closing Olefin Metathesis Synthetic Strategy(2005)74 cited
- → A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779(2012)62 cited
- → 2,7-Disubstituted-pyrrolo[2,1-f][1,2,4]triazines: New Variant of an Old Template and Application to the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors with in Vivo Antitumor Activity(2011)42 cited
- → Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes(2021)41 cited
- → Transition Metal Carbonyl Compounds(2004)36 cited
- → Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models(2010)34 cited
- → Diastereoselective Conjugate Additions to π-Allylmolybdenum Complexes: A Stereocontrolled Route to 3,4,5-Trisubstituted γ-Butyrolactones(2002)27 cited
- → Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review(2014)27 cited